Genentech (DNA): When Good News Is Bad
Genentech (DNA) announced that a new study uncovered that fact that its Avastin cancer drug can improve survival among people with severe lung cancer when it is added to other ...Read Full Story »
Daily Archives: June 2, 2007
Read Full Story »
GE (GE): The Bear Case
Barron's writes that GE's (GE) stock, which has been trading in the mid-$30s could go to $50. The magazine's article is fairly convincing. The company has sold off dogs like ...Read Full Story »
The Thugs At GlaxoSmithKline (GSK)
After bad-mouthing research attacking its diabetes drug Avandia, word now comes from The New York Times that GlaxoSmithKline (GSK) attempted to intimidate a well-known diabetes researcher, Dr. John Buse. The ...Read Full Story »
Harry Potter, The Stock Investor (SCHL)
Scholastic Corp. (SCHL-NASDAQ) made an announcement after Friday's close that the company was starting a $200 million accelerated share buyback plan via Deutsche Bank. The company expects to repurchase an ...Read Full Story »
Cramer Thinks Navteq Could Get a Bid
Last night on CNBC's Mad Money, Jim Cramer had an interesting thought regarding merger rumors and speculation. it was his 'Speculation Friday" after all. He surmized that Navteq Corp. (NVT-NYSE) ...Read Full Story »
-
Categories:
- 24/7 Wall St. Wire (3376)
- Accounting (283)
- Activist Investor (250)
- ADR (534)
- Aerospace (111)
- After-Hours Activity (98)
- Agriculture (260)
- Airlines (303)
- Analyst Calls (2698)
- Annual Report (63)
- Apparel (208)
- Austerity (33)
- auto (15)
- Autos (1162)
- Bait Shop (91)
- Banking (1663)
- Bankruptcy (202)
- Biotech (726)
- Blogs (5)
- Bonds (384)
- Brokerage Firms (437)
- Buffett (301)
- Buffett Holdings (31)
- business and finance (27)
- Business Services (177)
- Cable Companies (128)
- Calendar (226)
- Casinos (67)
- Charts (107)
- China (857)
- Commodities (636)
- Compensation (309)
- Conglomerates (424)
- Consumer Electronics (1098)
- Consumer Goods (502)
- Corporate Governance (491)
- Cramer (728)
- Cult Stock (191)
- Currency (127)
- Defense (75)
- Defensive Stocks (116)
- Dividend (512)
- Drug companies (276)
- Earnings (2938)
- Earnings Warning (447)
- Economy (2465)
- Editor's Picks (458)
- Emerging Markets (195)
- Entertainment (570)
- ETF (532)
- Exchange (43)
- Exchange News (121)
- FDA (90)
- Financial Stocks (1182)
- Food (592)
- General (3668)
- Green Biz (878)
- Alternative Energy (838)
- Hardware (207)
- Healthcare (173)
- HI/LOW (711)
- Housing (679)
- Index (288)
- Industry (157)
- Technology (117)
- Semiconductors (38)
- Technology (117)
- Infrastructure (197)
- Insider Activity (217)
- International Markets (2079)
- Internet (1720)
- Interview (53)
- IPOs (998)
- Labor & Unions (451)
- Large Cap Stocks (129)
- Law (404)
- Luxury (156)
- Management Change (629)
- Market Close (159)
- Market Open (191)
- Market Roundups (40)
- Media (861)
- Medical (238)
- Mergers and Buy Outs (1867)
- Metals (460)
- Micro Cap (7)
- Most Actives (31)
- Mutual Funds (224)
- Nanotech (8)
- Newsletter (7)
- Nuclear (74)
- Oil & Gas (1855)
- Old Media (206)
- Options (106)
- OTC (25)
- PC Companies (613)
- Personal Finance (79)
- Pharmaceuticals (227)
- Politics (567)
- Polls (23)
- Pre-Market Activity (757)
- Press Digest (1350)
- Private Equity (432)
- Product Review (62)
- Regulation (472)
- REIT (89)
- Research (1586)
- Restatements (23)
- Retail (1255)
- Rumors (876)
- Satellite (273)
- SEC (164)
- Secondary Offering (529)
- Semiconductor (638)
- Shareholder Issues (475)
- Short Interest (326)
- Small Cap Stocks (20)
- Software (766)
- Special Report (125)
- Stock Buybacks (173)
- Stock Splits (60)
- Tax (86)
- Technical Analysis (99)
- Technology Companies (1340)
- Telecom (657)
- The Day (84)
- The Week (148)
- Tobacco (47)
- Trading Alert (960)
- Transports (250)
- Turnarounds (210)
- TV (86)
- Utilities (283)
- Value Investing (330)
- Video Games (204)
- Water (55)
- WiMAX (164)
- Wireless (966)
